Category - Developments

Developments

Modular announces next-gen Pivot insulin pump at ADCES

Modular Medicine (NASDAQ: MODD) has announced its participation at the Association of Diabetes Care & Education Specialists (ADCES) Conference, August 8 to 11, 2025, where it will debut a coming soon campaign for...

August 8, 2025

Developments

Orchestra launches FDA-approved study protocol expanding patient eligibility criteria

Orchestra BioMed (NASDAQ: OBIO) has announced the roll out of an FDA-approved protocol update that enables a significant expansion in patient eligibility criteria for enrollment of its BACKBEAT study evaluating AVIM...

August 8, 2025

Developments

IDMC gives Elicio green light to continue study of ELI-002 7P in PDAC

Elicio Therapeutics (NASDAQ: ELTX) has announced that the Independent Data Monitoring Committee (IDMC) has recommended that its Phase 2 AMPLIFY-7P study in mutant KRAS (mKRAS)-driven pancreatic ductal adenocarcinoma...

August 5, 2025

Developments

Cadrenal reveals clinical trial plans for tecarfarin in ESKD

Cadrenal Therapeutics (NASDAQ: CVKD) has announced clinical trial initiation plans for its lead late-stage candidate, tecarfarin, for the treatment of patients with end-stage kidney disease (ESKD) transitioning to...

August 5, 2025

Developments

Perimeter joins a select group of medtech innovators in the NVIDIA Connect program

In a LinkedIn post today, Perimeter Medical Imaging AI (TSXV:PINK; OTCQX:PYNKF) revealed that it is now a member of the NVIDIA Connect Program. The company joins other medtech innovators that have recently been accepted...

July 30, 2025

Developments

Perimeter CEO significantly adds to holdings

According to a press release issued by Perimeter Medical Imaging AI (TSXV:PINK; OTCQB:PYNKF), it closed the final tranche of a prospectus offering of units of the company, in which its CEO, Adrian Mendes, participated...

July 29, 2025

Developments

Cook Medical’s launch of new iMRI division may help pave the way for wider and faster adoption of innovative procedures, like Profound’s TULSA

Cook Medical, a large family-owned medical device company known for its focus on minimally invasive treatment options, has launched a new Interventional Magnetic Resonance Imaging (iMRI) division, marking a significant...

July 29, 2025

Developments

Cognito presents positive Spectris data at AAIC; highlights Firefly collaboration for biomarker discovery using BNA technology

Closely held Cognito Therapeutics has announced five new poster presentations at the Alzheimer’s Association International Conference (AAIC) 2025, supporting the clinical efficacy and neuroprotective mechanism of its...

July 29, 2025

Developments

VVT Med completes RTO of V.V.T. Med and Exiteam Acquisition

VVT Med (TSXV: DXI.H) (formerly DXI Capital) announced that it has completed its previously announced acquisition of all of the outstanding securities of V.V.T. Med (VVT) and Exiteam Acquisition (EAC), according to the...

July 23, 2025

Developments

USPTO grants Enveric second patent allowance for next-gen mescaline derivatives

Enveric Biosciences (NASDAQ: ENVB) announced that the U.S. Patent and Trademark Office (USPTO) has granted a second Notice of Allowance for novel compounds within its next-generation, non-hallucinogenic mescaline...

July 23, 2025

Category - Developments

Subscribe